Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked to develop new ways of battling viruses like the ones that cause hepatitis delta and the common cold—but the lessons they’ve learned fighting viruses has led to a new kind of drug that has been effective at treating cancer in mice.
Read More